NDSL 3,022 Link page¿¡¼­ [¿ø¹®º¸±â] ¹öÆ°À» Ŭ¸¯Çϼ¼¿ä.

[±¹³» ÇÐÀ§³í¹®]

º» ³í¹®¿¡¼­´Â Àú°¡ÀÇ Standard CMOS 0.18¥ìm °øÁ¤À» »ç¿ëÇÏ¿© Self-adaptive APSÀÇ ¼º´ÉÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â photogate engineering°ú °ü·ÃÇÏ¿© ±× ¿ø¸®¸¦ Á¦½ÃÇÏ°í ÃøÁ¤À» ÅëÇÏ¿© ±× Ư¼ºÀ» ºÐ¼®ÇÏ¿´´Ù. 1Àå¿¡¼­´Â ¿¬±¸ÀÇ ¹è°æ°ú ³í¹®ÀÇ ±¸¼º¿¡ ´ëÇؼ­ ¸»ÇÏ¿´´Ù. 2Àå¿¡¼­´Â À̹ÌÁö ¼¾¼­ÀÇ ±âÃÊ ¹× ¹è°æ¿¡ ´ëÇؼ­ ¼³¸íÀ» ÇÏ¿´´Ù. ¿ì¼± ±¤ÇÐÀû Á¤º¸¸¦ Àü±âÀû Á¤º¸·Î º¯È¯À» ÇÏ´Â °úÁ¤¿¡ ´ëÇØ ¼³¸íÀ» ÇÏ°í ±âÁ¸ÀÇ pixel±¸Á¶¿¡ ´ëÇÑ ¼³¸í ¹× ¼º´ÉÀ» °áÁ¤ÇÏ´Â ¿©·¯ °¡Áö ¿ä¼Ò¿¡ ´ëÇØ ¼Ò°³ÇÑ´Ù. ±×¸®°í ±âÁ¸¿¡ Á¦¾ÈµÈ Self-adaptive APSÀÇ ±¸Á¶ ¹× µ¿ÀÛ¿ø¸®, Conventional APS¿ÍÀÇ ¼º´É ºñ±³¸¦ Á¦½ÃÇÏ¿´´Ù. 3Àå¿¡¼­´Â Self-adaptive APSÀÇ dark signal ¼º´ÉÀ» ÃÖÀûÈ­Çϱâ À§ÇØ photogate engineering°ú °ü·ÃµÈ ³»¿ë¿¡ ´ëÇØ ¼³¸íÀ» ÇÏ¿´´Ù. ¿ì¼± Self-adaptive APS ±¸Á¶¿¡¼­ dark signal ¿¡ ¿µÇâÀ» ÁÖ´Â ¿äÀε鿡 ´ëÇؼ­ ¼³¸íÀ» ÇÏ°í photogate bias¿Í size¸¦ Á¶ÀýÇÏ¿© dark signal¼º´ÉÀÌ ÃÖÀûÈ­µÇ´Â Á¶°ÇÀ» ¼³Á¤ÇÑ µÚ Optical response¸¦ ÃøÁ¤ÇÏ¿© ÀüüÀûÀÎ ¼º´ÉÀ» ºñ±³ÇÏ¿´´Ù. À̸¦ ÀÌ¿ëÇÏ¿© Dynamic Range¸¦ Çâ»ó½ÃÅ°±â À§ÇÑ »õ·Î¿î ¹æ¹ýÀÇ photogate ±¸µ¿ ¹æ¹ý¿¡ ´ëÇÏ¿© ¼³¸íÀ» ÇÑ ÈÄ ÀÌ¿¡ ´ëÇÑ ÃøÁ¤ °á°ú¸¦ º¸¿´´Ù. 4Àå¿¡¼­´Â Self-adaptive APS¿¡ »ç¿ëµÈ photogate·Î ÀÎÇÑ Quantum Efficiency degradationÀ» photogate size¸¦ Á¶ÀýÇϸç ÃøÁ¤À» ÇÏ¿´°í, Self-adaptive APSÀÇ high conversion gain mode¸¦ ÀÌ¿ëÇÏ¿© Spectral Response°¡ Çâ»óµÊÀ» º¸¿´´Ù. ¸¶Áö¸· 5Àå¿¡¼­´Â ¿¬±¸ °á°ú¸¦ Á¤¸®ÇÏ°í Á¾ÇÕÀûÀÎ ºÐ¼®À» ÇÑ µÚ °á·ÐÀ» ¸Î°í ¾ÕÀ¸·ÎÀÇ ¿¬±¸ °úÁ¦¸¦ Á¦½ÃÇÏ¿´´Ù.

[±¹³» ÇÐÀ§³í¹®]

º» ³í¹®¿¡¼­´Â ¹Ì¼¼ÆÐÅÏ Çü¼ºÀ» À§ÇÑ ºñÁ¤Áú Se_(75)Ge_(25) ¹Ú¸·ÀÇ Æ÷ÁöƼºêÇü ¹× ³×°¡Æ¼ºêÇü Æ÷Åä·¹Áö½ºÆ®¿¡ ´ëÇؼ­ °íÂûÇÏ¿´´Ù. ¹«±âÁú a-Se_(75)Ge_(25) Æ÷Åä·¹Áö½ºÆ®´Â I-line ½ºÅÇÆÛÀÇ ±¤³ëÃâ¿¡ ÀûÇÕÇÑ Æ÷Åä·¹Áö½ºÆ® Àç·áÀ̸ç Æ÷ÁöƼºêÇü Æ÷Åä·¹Áö½ºÆ®º¸´Ù´Â ³×°¡Æ¼ºêÇü Æ÷Åä·¹Áö½ºÆ®·Î »ç¿ëµÉ °æ¿ì ´õ¿í ³ôÀº °¨µµ¸¦ ³ªÅ¸³Â´Ù. ½À½ÄÇö»ó ¹æ½ÄÀ» ÅëÇØ ´ëºñµµ°¡ ³×°¡Æ¼ºêÇüÀÎ °æ¿ì¿¡ 2.9¸¦ ³ªÅ¸³Â°í Æ÷ÁöƼºêÇüÀÎ °æ¿ì¿¡ 1.4¸¦ ³ªÅ¸³»¹Ç·Î ³×°¡Æ¼ºêÀÎ °æ¿ì ¹Ì¼¼¼±Æø Á¶Àý´É·ÂÀÌ ´õ ¿ì¼öÇÔÀ» ¾Ë ¼ö ÀÖ¾ú´Ù. ³×°¡Æ¼ºêÇüÀ¸·Î »ç¿ëÇϱâ À§ÇÑ ±¤µµÇÎÀÇ °æ¿ì¿¡ ÀÖ¾î, Ag/a-Se_(75)Ge_(25) ¹Ú¸·¿¡ ÀúÇ׺¯È­°¡ ¹ß»ýµÆ´Ù. Ag/a-Se_(75)Ge_(25)ÀÇ ³×°¡Æ¼ºêÇü Æ÷Åä·¹Áö½ºÆ®¸¦ ÀÌ¿ëÇÔÀ¸·Î½á 0.8§­ Á¤µµÀÇ ¹Ì¼¼ÆÐÅÏÀ» Çü¼ºÇÒ ¼ö ÀÖ¾ú´Ù.

[±¹³»³í¹®]

A series of changes, which take place following the revolution of catching moment in the 1880s, such as amateur photograph, movie, cubism, futurism, photodynamism, and photo-journalism, are shown as a new paradigm different from the previous traditional reproduction from the corner of the 20th century. It directly implies the revival of time and velocity. Just amidst the revolution of this reproduction, there was chronophotography of Etienne-Jule Marey. In particular, chronophotography, which was utilized as the trace of movement in common by Italian futurists¡¯ picture or a photograph, is shown as the mental reappearance that was selected for revealing their radical consciousness from impression or effect of movement, not a scientific record or a simple formative tool of the moving substance. Futurists craved for revolution and innovation in the new world that most masses demanded in the socially and politically turbulent period at that time. Also, their artistic performance was believed to be capable of constructing new utopia. A photo, which was utilized for reproducing the movements in early futurists¡¯ formative works, has a form of sequence that shows consecutive motion, but is indicated as the trace of energy that shows gradual extinction and trace in the progressive motions, namely, as the trajectory of movement hinting at dynamics. However, what is important here is not what records a flow of movement or analyzes it with continual stage, but what makes a dynamic scene and its impression as the performance under the development in a scene. Also, Marey¡¯s chronophotography becomes much more effective tool for artists who try to reproduce movement, velocity, exercise, anxiety, agitation, rhythm and pattern of the theme through such trace, rather than reviving physical mark itself of movement. In conclusion, as the dynamism in futurism, which aims to construct the new world through social revolution, is a signal of every life that is vividly alive, it is shown as the graphic dynamism of a photo that revives trace and life of movement.

[±¹³» ÇÐÀ§³í¹®]

Æú¸®À̵̹å´Â ³»¿­¼º, Àü±âÀý¿¬¼º ¹× ±â°èÀû Ư¼ºÀÌ ¿ì¼öÇÏ¿© ÀüÀÚ ¹× ¹ÝµµÃ¼, ÀÚµ¿Â÷, Àü±â, Ç×°ø»ê¾÷ºÎÅÍ ¿ìÁÖ»ê¾÷±îÁö ´Ù¾çÇÏ°Ô »ç¿ëµÇ¾î ¿Ô´Ù. ±× Áß¿¡¼­µµ °¨±¤¼º Æú¸®À̵̹å´Â ¹Ì¼¼ÆÐÅÏ Á¦Á¶Çü¼ºÀÌ °¡´ÉÇÑ °í³»¿­¼º Æ÷Åä·¹Áö½ºÆ®·Î¼­ ÀÀ¿ëµÇ¾î ¿Ô´Ù.
 º» ¿¬±¸¿¡¼­´Â ÀûÃþÇü ÀüÀÚ¼ÒÀÚ¿ë °í³»¿­ Àý¿¬¸· ¼ÒÀç·Î »ç¿ëÇϱâ À§ÇÏ¿© 4,4'-oxydiphthalic anhydride (ODPA) »êÀ̼ö¹°°ú, 3,3',5,5'-tet
 ramethyl-4,4'-bis(p-aminophenoxyl)biphenyl (BBPA) µð¾Æ¹ÎÀ» »ç¿ëÇÏ¿© »õ·Î¿î ±¤°æÈ­Çü Æú¸®¾Æ¹Í»ê ¿¡½ºÅ׸£ PSPAE(ODPA-BBPA-HE
 MA)¸¦ ÇÕ¼ºÇÏ¿´´Ù. ÇÕ¼ºÇÑ PSPAE¸¦ NMP¿¡ ³ìÀÎ ÈÄ TEGDA(°¡±³Á¦)¿Í SPI-03(±¤°³½ÃÁ¦)¸¦ ÷°¡ÇÏ¿© ³×°¡Æ¼ºê ±¤°æÈ­Çü PSPAE Á¶¼º¹°À» Á¦Á¶ÇÏ¿´´Ù. ÀÌ PSPAE Á¶¼º¹°À» ½ºÇÉ ÄÚÆÃÇÏ¿© Á¦ÀÛÇÑ PSPAE-F1 Çʸ§À» ´Ü°èÀû ½Â¿Â °øÁ¤À¸·Î 350 oC¿¡¼­ À̵̹åÈ­ÇÏ¿© Æú¸®À̵̹å Çʸ§(PI-F1)À» ¾ò¾ú´Ù.
 PSPAE-F1°ú PI-F1 Çʸ§ÀÇ TGA °î¼±À» ±â·ÏÇÏ°í ¿­Àû°Åµ¿À» Á¶»çÇÏ¿´´Ù. ÃÖÁ¾ÀûÀ¸·Î´Â PSPAE-F1 Çʸ§À» ±¤ÆÐÅÍ´×ÇÏ°í À̵̹åÈ­ÇÔÀ¸·Î½á 20-100 ¥ìmÀÇ Çػ󵵸¦ °®´Â 4 ¥ìm µÎ²²ÀÇ ÆÐÅÍ´×µÈ PI Çʸ§À» Á¦Á¶ÇÒ ¼ö ÀÖ¾ú´Ù.

[±¹³» ÇÐÀ§³í¹®]

ÇöÀç ±¹³»ÀÇ ¹ÝµµÃ¼ ¹× µð½ºÇ÷¹ÀÌ »ê¾÷Àº ±¹°¡ÀÇ ÁÖ¿ä ±â°£»ê¾÷À¸·Î¼­ ÀÚ¸® Àâ°í ÀÖÀ¸¸ç ±âº»ÀûÀ¸·Î ÆÐÅÍ´×(patterning)°øÁ¤À» Æ÷ÇÔÇÏ°í ÀÖ´Ù. ÀÌ·¯ÇÑ ÆÐÅÍ´×(patterning)°øÁ¤ Áß Æ÷Åä·¹Áö½ºÆ®(photoresist)¿¡ ¹ß»ýÇÏ´Â ½ºÄÄ(scum) Á¦°Å¸¦ À§ÇÏ¿© Áø°øÀåÄ¡ ´ëºñ ½Ã½ºÅÛÀÇ ±¸Á¶°¡ ´Ü¼øÇÏ°í, Á¦ÀÛ, À¯Áö º¸¼öºñ¿ë µîÀÇ Àý°¨ È¿°ú°¡ ±â´ëµÇ´Â ´ë±â¾Ð ÇöóÁ¸¦ ÀÌ¿ëÇÑ ¾Ö½Ì ½Ã½ºÅÛ(ashing system) °³¹ßÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú´Ù.º» ¿¬±¸¿¡¼­´Â Æ÷Åä·¹Áö½ºÆ®(photoresist)¿¡ »ý¼ºµÈ ½ºÄÄ(scum) Á¦°Å¸¦ ¸ñÀûÀ¸·Î Æ÷Åä·¹Áö½ºÆ® ¾Ö½Ì ½Ã½ºÅÛ(photoresist ashing system) °³¹ß¿¡ À־, Ä¡¸íÀûÀÎ ÀÎÀÚ·Î ¼±Á¤µÈ Æ÷Åä·¹Áö½ºÆ® ¾Ö½Ì Çìµå(photoresist ashing head)ÀÇ ¼³°è ¹× °³¹ßÀ» À§ÇÏ¿© ¿¹»óµÇ´Â ¸®½ºÅ©(risk)¸¦ ù° ½ÇÇèÀåÄ¡¸¦ ±¸¼ºÇÏ¿© »çÀü ½ÇÇèÀ» ÅëÇÏ¿© °ËÁõÇÏ¿´°í, µÑ° ±ÕÀϼº(uniformity) °ËÁõÀ» À§ÇÑ °¡½º À¯µ¿Çؼ®(gas flow simulation)À» ½Ç½ÃÇÏ¿© °¡½º µð½ºÆ®¸®ºäÅÍ(gas distributor)ÀÇ ¼³°è°ªÀ» µµÃâÇÏ¿´´Ù. ³¡À¸·Î ¾Ö½Ì(ashing)¼º´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÇìµåÀÇ ¿©·¯ ÀÎÀÚ ¹× ¼öÁØÀ» ½ÇÇè°èȹ¹ýÀ» ÀÌ¿ë ÃÖÀû°ªÀ» µµÃâÇÏ¿´´Ù

[±¹³» ÇÐÀ§³í¹®]

Photodynamic therapy is a non-invasive cancer treatment method that can selectively laser irradiation on cancer tissue after the injection of photosensitizer. However, photodynamic therapy is necessary to develop a method that can enhance the cancer treatment efficiency due to limitation the light transmission and the anticancer activity of photosensitizer. This study was carried out to investigate the changes of anti-tumor effect of cisplatin on photodynamic therapy (PDT) with photolon in nude mouse tumor bearing model. The nude mouse tumor bearing model was prepared by injecting cultured colon cancer cells (CT26 cells, 1x105 cells/mouse) into the back of KSN/Slc nude mice. The experimental group was divided into the control group, the cisplatin group (3 mg/kg BW), 80 J/cm2 group, cisplatin+80 J/cm2 group and laser 140 J/cm2 group. Cisplatin (3 mg/kg BW) and photolon (2.5 mg/kg BW) were injected into the abdominal cavity and after 2 hours, laser light(660 nm) was irradiated on the tumor mass and the volume of tumor
 mass was measured with time. After 24 hours of laser irradiation, RNA was isolated from tumor tissues and gene expression changes were observed by mRNA sequencing analysis. The tumor volume of the control group was increased by 133% at day 8 compared to day 0, and 118% by the cisplatin treated group. The tumor volume in the 80 J/cm2 group increased by 68% on day 8 compared to day 0, and increased by 7% on day 8 compared to day 0 in the Cis+80 J/cm2 group. Tumor volume of 140 J/cm2 group was reduced by 27% on day 8. After 1 day of PDT, the tumor tissues were excised, fixed into 10% paraformaldehyde, stained with hematoxylin-eosine(HE) and observed under a light microscope. Necrotic cells were not observed in the tumor tissue of the control group and cisplatin groups. In the 80 J/cm2 group, necrosis was partially observed in the tumor tissue, and in the Cis+80 J/cm2 group, necrotic cells were extensively observed in the tumor tissue. After 1 day of PDT, mRNA-seq analysis of the expression of the genes involved in the immune response in the control and 80 J/cm2 groups showed no difference. In Cis+80 J/cm2 group, expression of genes involved in immune response was increased compared to 80 J/cm2 group. After 1 day of PDT, the expression of chemotaxis-related 12 genes and immune response-related 18 genes were different in cancer tissues of 80 J/cm2 group and Cis+80 J/cm2 group. The combination of cisplatin and photolon-PDT significantly reduced tumor size and increased the expression of immune response-related genes in tumor tissues.
 These results suggest that the combination of cisplatin and PDT may be an effective method for enhancing cancer treatment.

[±¹³» ÇÐÀ§³í¹®]

½ÅÀå¿¡¼­ ÇãÇ÷°ú ÀçÇ÷·ù¿¡ ´ëÇÑ ½ÅÀåÀÇ ¼Õ»óÀº ¹ý¸®»ý¸®Çп¡ °ü·ÃµÇ¾î ÀÖÀ¸¸ç, ÃÖ±Ù ¿¬±¸¿¡¼­´Â ½ÅÀå, ½ÉÀå, ³ú¿Í °°Àº ¿©·¯ ±â°ü¿¡¼­ ÇãÇ÷°ú ÀçÇ÷·ù½Ã¿¡ ¾ÆÆ÷Åä½Ã½º°¡ ¾ß±âµÇ´Â °ÍÀ» Áõ¸íÇÏ°í ÀÖ´Ù. ÈòÁã ½ÅÀåÀÇ ÇãÇ÷ ÈÄ¿¡ ½Å¼Õ»ó°ú ȸº¹°úÁ¤¿¡¼­ ¾ÆÆ÷Åä½Ã½º¿Í ¼¼Æ÷Áõ½ÄÀ» °üÂûÇÒ ¼ö Àִµ¥ º» ¿¬±¸¿¡¼­´Â 8ÁÖ ÀÌ»óµÈ ÈòÁ㸦 »ç¿ëÇÏ¿´´Ù. ÈòÁ㸦 ketamine ¸¶ÃëÇÏ¿¡ º¹ºÎÀý°³ÇÏ¿© °³º¹ÇÑ ÈÄ ½ÅÀåÀ» ³ëÃâ½ÃÅ°°í ÁÂÃø ½Åµ¿¸ÆÀ» 20, 40, 60, ¹× 120ºÐ µ¿¾È °áÂûÇÏ¿´´Ù. ÇÑ ±ºÀº °áÂûÀÌ ³¡³­ ÈÄ ½ÅÀåÀ» ÀûÃâÇÏ¿´À¸¸ç, ÇÑ ±ºÀº °áÂûÀ» Ç®°í, ÀçÇ÷·ù¸¦ ÀÌ·ç°Ô ÇÑ µÚ º¹ºÎÀý°³¸¦ ºÀÇÕÈÄ 24½Ã°£ ÈÄ¿¡ ketamine ¸¶ÃëÇÏ¿¡ º¹ºÎÀý°³·Î ½ÅÀåÀ» ÀûÃâÇÏ¿´´Ù. º» ½ÇÇè¿¡¼­´Â ¾óÀ½À¸·Î 4¡É¸¦ À¯Áö ÇÏ¿´À¸¸ç, Á¤»ó´ëÁ¶±ºÀº ½ÅÀåÁ¶Á÷À» ½Ç¿Â¿¡¼­ ÀûÃâÇÑ °ÍÀ» »ç¿ëÇÏ¿´´Ù. ½ÅÀåÀÇ ¾ÆÆ÷Åä½Ã½º¿Í ¼¼Æ÷Áõ½Ä´ÉÀÇ Æò°¡¸¦ À§ÇÑ ½ÅÁ¶Á÷ÀÇ °üÂûÀº TUNEL¹ýÀ» ÀÌ¿ëÇÑ ¸é¿ªÈ­ÇÐÀû ¹æ¹ý°ú Ki-67Ç×ü¸¦ ÀÌ¿ëÇÑ ¸é¿ª È­ÇÐÀû ¹æ¹ýÀ» ½ÃÇàÇÏ¿´´Ù. ½ÅÀ嵿¸ÆÀ» °áÂûÈÄ aprptosis´Â 20ºÐ¿¡¼­ºÎÅÍ °üÂûµÇ¾î ½Ã°£ÀÌ Áö³¯ ¼ö ·Ï Áõ°¡µÇ¾úÀ¸¸ç, ¾ÆÆ÷Åä½Ã½ºÀÇ ºÐÆ÷´Â ½Å¼öÁúº¸´Ù ½ÅÇÇÁú¿¡¼­ ´õ ¸¹ÀÌ °üÂûµÇ¾ú´Ù. ¶ÇÇÑ ½ÅÀ嵿¸ÆÀ» °áÂûÈÄ ¼¼Æ÷Áõ½ÄÀº ½Å¼öÁú¿¡¼­´Â 20ºÐ¿¡, ½ÅÇÇÁú¿¡¼­´Â 40ºÐ¿¡ ÃÖ°íÁ¶¸¦ º¸¿´À¸¸ç, ½Ã°£ÀÌ Áö³¯¼ö·Ï °¨¼ÒµÇ¾ú´Ù. ±×¸®°í ½ÅÀ嵿¸ÆÀ» °áÂûÈÄ ½Ã°£¿¡ µû¶ó ÀçÇ÷·ù¸¦ ½ÃŲ °æ¿ì, ½ÅÀåÇãÇ÷½Ã°£ÀÌ 20 ºÐÀ̾ú´ø °æ¿ì¿¡´Â apoptosis°¡ Àû¾úÀ¸³ª, ½ÅÀåÇãÇ÷½Ã°£ÀÌ 40ºÐÀ̾ú´ø °æ¿ì¿¡ ÀçÇ÷·ù¿¡ ÀÇÇÑ apoptosis´Â Áõ°¡µÇ¾ú´Ù. ÀÌ·¯ÇÑ ÀçÇ÷·ù¿¡ ÀÇÇÑ apoptosis´Â 60ºÐ ÀÌ»ó ÇãÇ÷½Ã°£ÀÌ Áö¼ÓµÈ °æ¿ì °¨¼ÒÇÏ´Â ¼Ò°ßÀ» º¸¿´´Ù. ¾ÆÆ÷Åä½Ã½ºÀÇ ºÐÆ÷´Â ÇãÇ÷½Ã°£ÀÌ ÂªÀ»¼ö·Ï ½Å¼öÁú¿¡¼­ ¸¹ÀÌ ³ªÅ¸³µÀ¸¸ç, 20ºÐ ÀÌ»óÀÇ ÇãÇ÷½Ã°£ÀÌ ÀÌ·ç¾îÁø °æ¿ì ½ÅÇÇÁú¿¡¼­ ´õ ¸¹ÀÌ °üÂûµÇ¾ú´Ù. ¼¼Æ÷Áõ½Ä¿¡ À־´Â ½ÅÀåÇãÇ÷½Ã°£ÀÌ 20, 40ºÐÀ̾ú´ø °æ¿ì¿¡ ÀçÇ÷·ù½Ã ¼¼Æ÷Áõ½ÄÀº Áõ°¡µÇÀÖ´Ù. ÀÌ·¯ÇÑ ÀçÇ÷·ù½ÃÀÇ ¼¼Æ÷Áõ½ÄÀº 40ºÐ ÀÌ»ó ÇãÇ÷½Ã°£ÀÌ Áö¼ÓµÈ °æ¿ì °¨¼ÒÇÏ´Â ¼Ò°ßÀ» º¸¿´´Ù. ¼¼Æ÷Áõ½ÄÀÇ ºÐÆ÷´Â ÇãÇ÷½Ã°£ÀÌ ÂªÀ»¼ö·Ï ½Å¼öÁú¿¡¼­ ¸¹ÀÌ ³ªÅ¸³µÀ¸¸ç, 40ºÐ ÀÌ»óÀÇ ÇãÇ÷½Ã°£ÀÌ ÀÌ·ç¾îÁø °æ¿ì´Â ½ÅÇÇÁú¿¡¼­ ¸¹ÀÌ ³ªÅ¸³µ´Ù ½ÅÀ嵿¸Æ °áÂû¿¡ µû¸¥ apoptosis´Â ½ÅÇÇÁúÀ̳ª ½Å¼öÁú¿¡¼­ ¸ðµÎ 40¡É·Î À¯Áö½ÃŲ °æ¿ì ½Ç¿Â¿¡ ºñÇØ À¯ÀÇÇÏ°Ô °¨¼ÒÇÏ¿´°í, ½ÅÀ嵿¸ÆÀÇ ÀçÇ÷·ù¿¡ ÀÇÇÑ ¾ÆÆ÷Åä½Ã½ºµµ ½ÅÇÇÁúÀ̳ª ½Å¼öÁú¿¡¼­ ¸ðµÎ 4¡É·Î À¯Áö½ÃŲ °æ¿ì ½Ç¿Â¿¡ ºñÇØ À¯ÀÇÇÏ°Ô °¨¼ÒÇÏ¿´´Ù. ¸¶Á÷¸·À¸·Î, ½ÅÀ嵿¸Æ °áÂû¿¡ µû¸¥ ¼¼Æ÷Áõ½ÄÀ» Á¶»çÇÑ °á°ú, ½ÅÇÇÁúÀ̳ª ½Å¼öÁú¿¡¼­ ¸ðµÎ 4¡É·Î À¯Áö½ÃŲ °æ¿ì ½Ç¿Â¿¡ ºñÇØ ÀÇÀÇÀÖ´Â º¯È­´Â ¾ø¾úÀ¸³ª, ½ÅÀ嵿¸ÆÀÇ ÀçÇ÷·ù¿¡ ÀÇÇÑ ¼¼Æ÷Áõ½ÄÀÌ ½ÅÇÇÁúÀ̳ª ½Å¼öÁú¿¡¼­ ¸ð.µÎ 4¡É·Î À¯Áö½ÃŲ °æ¿ì ½Ç¿Â¿¡ ºñÇØ À¯ÀÇÇÏ°Ô Áõ°¡ÇÏ¿´´Ù. ÀÌ»óÀÇ °á°ú¿¡¼­ ¾ÆÆ÷Åä½Ã½º´Â ½ÅÀåÀÇ ÇãÇ÷°ú Àç°ü·ù½Ã¿¡ ½Å¼Õ»óÀÇ ÁöÇ¥·Î Ư¡Àû ¼Ò°ßÀ¸·Î ³ªÅ¸³ª¸ç, ½ÅÀåÀç°Ç¼úÀ» ½ÃÇàÇÒ ¶§ Àú¿ÂÀ» À¯ÁöÇϰųª ÇãÇ÷½Ã°£À» ´ÜÃàÇÔÀ¸·Î¼­ ½Å¼¼Æ÷ÀÇ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖÀ¸¸®¶ó »ç·áµÈ´Ù.

[±¹³» ÇÐÀ§³í¹®]

°¨±¤¼º Æú¸®À̵̹å´Â Àü±âÀû Ư¼º, ³»¿­¼º µîÀÌ ¿ì¼öÇÏ¿© ¹ÝµµÃ¼ ¼ÒÀÚÀÇ º¸È£¸·À̳ª ´ÙÃæ¹è¼±ÀÇ Ãþ°£ Àý¿¬¸· µîÀ¸·Î »ç¿ëµÇ°í ÀÖ´Ù. °¨±¤¼º Æú¸®À̵̹å´Â ³×°ÅƼºêÇü°ú Æ÷ÁöƼºêÇüÀ¸·Î ºÐ·ùµÇ´Âµ¥, ÇöÀç±îÁö Æ÷ÁöƼºêÇü¿¡ ´ëÇؼ­´Â ³·Àº ±¤°¨µµ µîÀÇ ÀÌÀ¯ ¶§¹®¿¡ ¿¬±¸°¡ °ÅÀÇ ÁøÇàµÇ°í ÀÖÁö ¾Ê´Ù. º» ¿¬±¸¿¡¼­´Â Æ÷ÁöƼºêÇü Æú¸®À̵̹åÀÇ ±¤°¨µµ Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃß¾î, »õ·Î¿î ±¸Á¶ÀÇ Æú¸®À̵̹带 ÇÕ¼ºÇÏ°í °¨±¤¼º Æú¸®À̵̹å·Î¼­ÀÇ ÀÀ¿ë °¡´É¼ºÀ» Á¶»çÇÏ¿´´Ù. °íºÐÀÚ Áּ⿡ ±¤ºÐÇؼº ±¸Á¶·Î¼­ cyclobutane °í¸®¿Í sulfohyloxyimide(¶Ç´Â carbonyloxyimide) ±¸Á¶¸¦ µ¿½Ã¿¡ °¡Áö´Â 2Á¾·ùÀÇ Æ÷ÁöƼºêÇü °¨±¤¼º Æú¸®À̵̹带 ÃàÇÕÁßÇÕ¿¡ ÀÇÇØ ÇÕ¼ºÇÏ¿´´Ù, À̵é Æú¸®À̵̹å´Â ¾çÈ£ÇÑ ¹Ú¸·Çü¼ºÆ¯¼º, ¿ëÇصµ, ¿­Àû ¾ÈÁ¤¼ºÀ» ³ªÅ¸³Â´Ù. Àڿܼ± ºÐ±¤ºÐ¼®, Àû¿Ü¼± ºÐ±¤ºÐ¼®, GC-MS ºÐ¼® µîÀÇ ¹æ¹ýÀ¸·Î Æú¸®À̵̹åÀÇ ±¤ºÐÇØ °Åµ¿À» Á¶»çÇÏ¿´´Ù. µÎ °íºÐÀÚ °øÈ÷ 254nmÀÇ ¿øÀڿܼ± Á¶»ç¿¡ ÀÇÇØ N-O °áÇÕ°ú cyclobutane °í¸®°¡ °³¿­µÇ¾î maleimide¸¦ »ý¼ºÇÏ¿´´Ù. Æú¸®À̵̹åÀÇ ±¤°¨µµ¸¦ ÃøÁ¤ÇÑ °á°ú ±âÁ¸ÀÇ cyclobutane ±¸Á¶¸¸À» °¡Áö´Â Æú¸®À̵̹忡 ºñÇÏ¿© Çâ»óµÈ °¨µµ¸¦ ³ªÅ¸³Â´Ù. ƯÈ÷ sulfonyloxyimide ±¸Á¶¸¦ °¡Áø Æú¸®À̵̹å´Â ¾à 100mJ/§²ÀÇ ¿ì¼öÇÑ ±¤°¨µµ¸¦ ³ªÅ¸³Â´Ù. Æú¸®ÀÌ¹Ìµå ¹Ú¸·¿¡ ¿øÀڿܼ±À» Á¶»çÇÏ°í THF ¶Ç´Â Áõ·ù¼ö·Î Çö»óÇÑ °á°ú Æ÷ÁöƼºêÇüÀÇ ÆÐÅÏÀ» ¾òÀ» ¼ö ÀÖ¾ú´Ù.

[±¹³» ÇÐÀ§³í¹®]

¾ÆÆ÷Åä½Ã½º¿¡ ÀÇÇÑ ¼¼Æ÷»ç¸êÀº ¼¼Æ÷ÀÇ Áõ½ÄÀ» Á¶ÀýÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ÀϹÝÀûÀ¸·Î ¼¼Æ÷Áֱ⿡ °ü¿©ÇÏ´Â ¿©·¯ ÀÎÀڷκÎÅÍ ¿µÇâÀ» ¹Þ´Â´Ù. Á¾¾ç¾ïÁ¦À¯ÀüÀÚ·Î Àß ¾Ë·ÁÁ® ÀÖ´Â p53 À¯ÀüÀÚ´Â °æ¹ÌÇÑ ¼¼Æ÷¼Õ»óÀÌ ¹ß»ýÇÑ °æ¿ì¿¡´Â ¼¼Æ÷Áֱ⸦ ÁßÁö½ÃÄÑ DNA°¡ º¹±¸µÇ¾î ´Ù½Ã Á¤»óÀûÀÎ ¼¼Æ÷ÁÖ±â·Î µ¹¾Æ°¡µµ·Ï Çϸç, º¹±¸Çϱ⠾î·Á¿î Å« ¼Õ»óÀ» ¹Þ¾ÒÀ» ¶§´Â ¼¼Æ÷Áֱ⿡¼­ ¹þ¾î³ª ¾ÆÆ÷Åä½Ã½º¸¦ ÅëÇÏ¿© ¼¼Æ÷°¡ Á¦°ÅµÇµµ·Ï ÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. p53 À¯ÀüÀÚÀÇ µ¹¿¬º¯ÀÌ´Â Àΰ£ÀÇ ¾Ç¼º Á¾¾ç¿¡¼­ °¡Àå ÈçÇÏ°Ô ¹ß°ßµÇ´Â À¯ÀüÇÐÀûÀÎ ÀÌ»ó¼Ò°ßÀÓ¿¡µµ ºÒ±¸ÇÏ°í ±Þ¼º°ñ¼ö¼º¹éÇ÷º´(AML) °ú °ñ¼öÀÌÇü¼ºÁõÈıº(MDS) ¿¡¼­´Â ºñ±³Àû µå¹°°Ô °üÂûµÈ´Ù. p53 ´Ü¹é¿¡ ÀÇÇÑ ¾ÆÆ÷Åä½Ã½ºÀÇ À¯µµ¿¡ °ü¿©ÇÏ´Â ¿©·¯ ÀÎÀÚ Áß¿¡¼­ WAF-1 À¯ÀüÀÚ(CIP-1À̶ó°íµµ ºÒ¸²)ÀÇ »ê¹°ÀÎ p21 ´Ü¹éÀÌ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. p21 ´Ü¹éÀº Á¤»ó(wild type) p53¿¡ ÀÇÇÏ¿© À¯µµµÇ´Â ¹Ý¸é º¯ÀÌÇü p53¿¡ ÀÇÇؼ­´Â À¯µµµÇÁö ¾ÊÀ¸¹Ç·Î p53 À¯ÀüÀÚÀÇ ¾Ï¾ïÁ¦ÀÛ¿ëÀÌ p21 ´Ü¹éÀÇ ¹ßÇöÀ» ÅëÇÏ¿© ÀÌ·ç¾îÁø´Ù°í ÃßÁ¤ÇÏ°í ÀÖ´Ù. º» ¿¬±¸ÀÇ ¸ñÀûÀº °ñ¼öÀÌÇü¼ºÁõÈıº°ú ±Þ¼º°ñ¼ö¼º¹éÇ÷º´¿¡¼­ ¾ÆÆ÷Åä½Ã½ºÀÇ Àǹ̸¦ ¹àÈ÷°í º¯ÀÌÇü p53 ´Ü¹é ¹× p21 ´Ü¹é°úÀÇ ¿¬°ü°ü°è¸¦ ±Ô¸íÇÏ´Â °ÍÀÌ´Ù. ƯÈ÷ °¢ ÁúȯÀÇ ¾ÆÇü¿¡ µû¸¥ Â÷À̸¦ ºñ±³ÇÏ°í, °ñ¼öÀÌÇü¼ºÁõÈıºÀÌ ±Þ¼º°ñ¼ö¼º¹éÇ÷º´À¸·Î ÀüȯÇÏ´Â °úÁ¤¿¡¼­ À̵éÀÇ ¿ªÇÒÀ» È®ÀÎÇÏ°íÀÚ ÇÏ¿´´Ù. °ñ¼öÀÌÇü¼ºÁõÈıºÀ¸·Î Áø´ÜµÈ ȯÀÚ 24¿¹, ±Þ¼º°ñ¼ö¼º¹éÇ÷º´À¸·Î Áø´ÜµÈ ȯÀÚ 31¿¹ ¹× Á¤»ó °ñ¼ö¼Ò°ßÀ» º¸ÀÎ 17¿¹¸¦ Á¤»ó´ëÁ¶±ºÀ¸·Î Æ÷ÇÔÇÏ¿© ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù. °ñ¼öÀÌÇü¼ºÁõÈıºÀº Ãʱâ¿Í ¸»±â·Î ±¸ºÐÇÏ¿´´Ù. ±Þ¼º°ñ¼ö±¸¼º¹éÇ÷º´Àº de novo AMLÀÌ 25¿¹¿´°í MDS¿¡¼­ ÁøÇàµÈ AML(MDS-AML)ÀÌ 6¿¹¿´´Ù. °ñ¼ö»ý°Ë °ËüÀÇ ÆĶóÇÉ Æ÷¸ÅÁ¶Á÷¿¡¼­ ¾ÆÆ÷Åä½Ã½º´Â TUNEL(in situ NA end labeling)±â¼úÀ» ÀÌ¿ëÇÏ¿© ºÐ¼®ÇÏ¿´°í, º¯ÀÌÇü p53´Ü¹é ¹× p21´Ü¹éÀÇ ¹ßÇöÀº ¸é¿ªÁ¶Á÷È­Çа˻ç·Î ¿°»öÀ» ½Ç½ÃÇÏ¿© ´ÙÀ½°ú °°Àº °á°ú¸¦ ¾ò¾ú´Ù. 1. ¾ÆÆ÷Åä½Ã½º´Â °ñ¼öÀÌÇü¼ºÁõÈıº¿¡¼­ de novo AML, MDS-AML ¹× Á¤»ó´ëÁ¶±º¿¡ ºñÇØ À¯ÀÇÇÏ°Ô Áõ°¡µÇ¾î ÀÖ¾úÀ¸¸ç (P=0.011, P

[±¹³» ÇÐÀ§³í¹®]

¹ÝµµÃ¼ ÁýÀûȸ·ÎÀÇ °íµµÈ­¿¡ µû¶ó ±Ø ¹Ì¼¼ÆÐÅÏÀÌ ¿ä±¸ µÇ°í ÀÖÀ¸¸ç À̸¦ À§ÇÑ Æ÷Åä·¹Áö½ºÆ®ÀÇ °³¹ßÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖ´Ù. ³ë±¤ ¿øµµ ÇöÀç ArF (193 nm) stepper°¡ KrF (248 nm)¸¦ ´ë½ÅÇÏ°í ÀÖÁö¸¸, Èí±¤µµ³ª ³»¿¡Äª¼º µî ¸ðµç Á¶°ÇÀ» ¸¸Á·ÇÏ´Â ·¹Áö½ºÆ®´Â Á¦½ÃµÇÁö ¸øÇÏ°í ÀÖ´Ù. ´õ¿íÀÌ aspect ratio°¡ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ÆÐÅÏÀÇ º¯ÇüÀ̳ª ºØ±«´Â wet development °øÁ¤À» »ç¿ëÇÏ´Â ±âÁ¸ÀÇ °øÁ¤¿¡¼­´Â ÇÊ¿¬ÀûÀÌ´Ù. º» ¿¬±¸ÀÚ´Â 193 nm¿¡ Àû¿ë °¡´ÉÇÏ°í, 2.38 wt% TMAH developer¸¦ »ç¿ëÇÑ wet developing »Ó¸¸ ¾Æ´Ï¶ó $O_2$ RIE¸¸À¸·Î °Ç½Ä Çö»óÀÌ °¡´ÉÇÑ »õ·Î¿î ·¹Áö½ºÆ®¸¦ °³¹ßÇÏ¿´´Ù. »õ·ÎÀÌ ¼³°è ÇÕ¼ºµÈ º» ·¹Áö½ºÆ®´Â 193 nm¿¡ Àû¿ëÇÒ ¼ö ÀÖÀ¸¸ç, °¨µµ, Åõ¸í¼º, ¿­Àû ¾ÈÁ¤¼º µî ·¹Áö½ºÆ®·Î¼­ °¡Á®¾ß ÇÒ ¿ì¼öÇÑ Æ¯¼ºÀ» ¸ðµÎ °¡Áö°í ÀÖÀ½À» È®ÀÎÇÏ¿´´Ù. ³ë±¤°ú PEB¿¡ ÀÇÇØ È­ÇÐÁõÆøÇüÀ¸·Î Á¦°Å µÉ ¼ö ÀÖ°í ÀÚü¿¡ ½Ç¸®ÄÜÀ» ÇÔÀ¯ÇÏ°í ÀÖ´Â »õ·Î¿î protecting groupÀ» 193 nm¿¡¼­ Åõ¸íÇÑ ¸ÞŸũ¸±·¹ÀÌÆ®¿¡ µµÀÔÇÏ¿© ½Å±Ô ¸ð³ë¸Ó¸¦ ÇÕ¼ºÇÑ ÈÄ, ¶óµðÄ® ÁßÇÕ¿¡ ÀÇÇØ ·¹Áö½ºÆ®·Î »ç¿ëµÉ ¼ö ÀÖ´Â ¸ÅÆ®¸¯½º °íºÐÀÚ¸¦ Á¦Á¶ÇÏ¿´´Ù. »õ·Î¿î protecting groupÀº ÀÚü¿¡ ÇÔÀ¯µÈ ½Ç¸®ÄÜ ¿ø¼Ò¿¡ ÀÇÇØ ÀϹÝÀûÀÎ protecting group°ú´Â ´Ù¸¥ ºÐÇØ Æ¯¼ºÀ» º¸¿´À¸³ª, º» ¿¬±¸ÀÚ´Â ±¤»ê¹ß»ýÁ¦ (PAG)¿¡ µû¸¥ ºÐÇØ ¸ÞÄ«´ÏÁòÀ» ¹àÇô ½ÇÁ¦ »ó¾÷È­ ½Ã ¾ÈÁ¤ÀûÀ¸·Î »ç¿ëµÉ ¼ö ÀÖ°Ô ÇÏ¿´´Ù. ±âÁ¸ÀÇ °Ç½ÄÇö»óÀº silylation °øÁ¤ÀÌ Ãß°¡µÇ°Å³ª, imaging layer¸¦ ½À½ÄÇö»ó ÇÑ ÈÄ °Ç½ÄÇö»óÀ» Àû¿ëÇØ¾ß ÇÏ´Â ¹®Á¦Á¡ÀÌ ÀÖ¾ú´Ù. Imaging layer¸¦ ½À½ÄÇö»ó ÇÏÁö ¾Ê´Â °æ¿ìµµ ÀÖ±ä ÇÏ¿´Áö¸¸, ±× °æ¿ì´Â ¾ÆÁÖ ¸¹Àº ¿¡³ÊÁö¸¦ »ç¿ëÇÏ¿© ·¹Áö½ºÆ® ÁßÀÇ ¸ÅÆ®¸¯½º °íºÐÀÚ Áּ⸦ Àý´ÜÇϰųª, ¸ð³ë¸Ó ÇüÅÂÀÇ ½Ç¸®ÄÜ È­ÇÕ¹°À» ³ôÀº ¿¡³ÊÁö¿¡ ÀÇÇØ ÁßÇÕ½ÃÅ°´Â Á¤µµ¿´´Ù. º» ¿¬±¸¿¡¼­´Â sensitivity°¡ ¾ÆÁÖ ÁÁÀº °ÍÀ¸·Î Áõ¸íµÇ°í ÇöÀç °ÅÀÇ ¸ðµç ·¹Áö½ºÆ®°¡ »ç¿ëÇÏ´Â È­ÇÐÁõÆø ¹ÝÀÀÀ» ÀÌ¿ëÇÏ¿©, ½Ç¸®ÄÜÀÌ ³ë±¤°ú PEB¿¡ ÀÇÇØ Á¦°Å µÉ ¼ö ÀÖµµ·Ï ¼³°è ÇÕ¼ºÇÏ¿´´Ù. ±×¸®°í ½ÇÁ¦ °øÁ¤¿¡ Àû¿ëÇÏ¿© Oxygen reactive ion etching ($O_2$-RIE)¸¸À¸·Î Çö»óÀ» ÇÏ¿© ¹Ì¼¼ÆÐÅÏÀ» ¾ò¾ú´Ù.

[±¹³» ÇÐÀ§³í¹®]

½º¸¶Æ®ÆùÀÇ À§¼ºÇ×¹ýÀåÄ¡(GPS)¿Í À̵¿½Ä ³×Æ®¿öÅ©¸¦ ÀÌ¿ëÇÑ À§Ä¡±â¹Ý ¼­ºñ½º´Â ´Ù¾çÇÑ ºñÁî´Ï½º ¸ðµ¨À» Á¦°øÇÑ´Ù. ÇöÀç »ç¿ëÀÚÀÇ À§Ä¡Á¤º¸¸¦ ÀÌ¿ëÇÏ¿© ÁÖº¯ÀÇ À½½ÄÁ¡, ¼÷¹Ú¾÷¼Ò, °ü±¤ÁöµîÀÇ Á¤º¸¸¦ Á¦°øÇÏ´Â ¡°ÁÖº¯Á¤º¸Á¦°ø¡± ¼­ºñ½º¿Í ±æ ã±â, ±³ÅëÁ¤º¸, ¹ö½º¾È³»¿Í °°ÀÌ ¡°Áö¸®Á¤º¸¼­ºñ½º¡± ÇüÅÂÀÇ ¼­ºñ½º À¯ÇüÀÌ ³ª¿Í ÀÖ´Ù. ÃÖ±Ù¿¡´Â Çö½Ç°ú °¡»óÀÇ ¼¼°è¸¦ ´õÇÏ¿© »ç¿ëÀÚ¿¡°Ô ´Ù¾çÇÑ ºÎ°¡Á¤º¸¸¦ Á¦°øÇÏ´Â Áõ°­Çö½Ç ¼­ºñ½º¿Í µðÁöÅÐ »çÁø°ú GPS ÃøÀ§±â¼úÀ» °áÇÕ½ÃÄÑ Æ¯Á¤Áö¿ª¿¡¼­ ÃÔ¿µÇÑ »çÁøÀ» ÁöµµÀÇ ÃÔ¿µÁö¿¡ Ç¥½ÃÇÏ´Â GPS Æ÷Åä ¶ÇÇÑ °¢±¤À» ¹Þ°í ÀÖ´Ù. ÃÖ±Ù ±¹³»ÀÇ ÁöÀÚü³ª °ø°ø±â°üµéÀº Áö¿ªÀÇ ¹®È­À¯»ê°ú °ü±¤ÀÚ¿øÀ» °³¹ßÇÏ°í È°¿ëÇÏ´Â ´Ù¾çÇÑ »ç¾÷À» ÁøÇàÇÑ´Ù. °ü±¤À¸·Î ÀÎÇÑ ¼öÀÍÀº Áö¿ªÀÇ »ýÅÂ°è º¸ÀüÀ̳ª Áö±¸È¯°æÀÇ ½É°¢¼ºÀ» ¾Ë¸®°í, »ýÅÂ°è º¸È£¸¦ üÇèÇÏ´Â »ýÅ°ü±¤(eco-tourism) »ç¾÷¿¡ ¸¹Àº ¿¹»êÀ» ÅõÀÔÇÏ°í ÀÖ´Ù. ÀÌÁ¦´Â ´Ü¼øÈ÷ °ü±¤Áö¸¦ º¸¸ç Áñ±â´Â °ÍÀÌ ¾Æ´Ñ ȯ°æ º¸Àü¿¡ Âü¿©ÇÏ°í, Áö¿ª°æÁ¦¿¡ ¹®È­Àû⦁°æÁ¦ÀûÀ¸·Î °øÇåÇϸç, °ü±¤°´µé¿¡°Ô ÇöÀåÇнÀÀÇ °æÇèÀ» Á¦°øÇØ¾ß ÇÏ´Â °ÍÀÌ´Ù. ¶ÇÇÑ °ü±¤Áö¿¡ ´ëÇÑ Á¤º¸¸¦ ¿Â¶óÀλ󿡼­ °øÀ¯ÇÏ¿©, ´Ù¾çÇÑ ±¹³» °ü±¤ ÀÚ¿øÀÇ ¾Ë¸®´Â ³ë·Âµµ ÇÔ²² ÁøÇàÇÏ°í ÀÖ´Ù. º» ³í¹®¿¡¼­´Â À§Ä¡±â¹Ý ¼­ºñ½º¿¡ ÇÊ¿äÇÑ ÃøÀ§±â¼úÀÇ ÇüÅÂ¿Í ºñÁî´Ï½º ¸ðµ¨¿¡ ´ëÇØ ¾Ë¾Æº»´Ù. ±×¸®°í À¯ºñÄõÅͽº °ü±¤Á¤º¸ ¼­ºñ½ºÀÇ Á¾·ù¿¡ ´ëÇØ ¾Ë¾Æº»´Ù. ¶ÇÇÑ ½º¸¶Æ®ÆùÀ» ÀÌ¿ëÇÏ¿© °ü±¤°´ÀÇ À§Ä¡¸¦ ÀÎÁöÇÏ¿© ¸ÖƼ¹Ìµð¾î ÄÜÅÙÃ÷¸¦ Á¦°øÇÏ°í ÇöÁö¸¦ ¹æ¹®ÇÏ°í ´À³¤ ¿©ÇàÀÇ ±âÇ๮À» À̹ÌÁö, ÅؽºÆ® ±×¸®°í µ¿¿µ»ó ÇüÅ·Π¼­¹ö¿¡ µî·ÏÇÏ¿© »ç¿ëÀÚ°£¿¡ Á¤º¸¸¦ °øÀ¯ÇÏ´Â ¹æ¾ÈÀ» Á¦½ÃÇÏ°í ±¸ÇöÇÏ¿´´Ù.

[±¹³»³í¹®]

[±¹³»³í¹®]

Æ÷Åä ¸ðÀÚÀÌÅ©´Â ÀÔ·Â À̹ÌÁö¸¦ ÀÛÀº ŸÀÏ À̹ÌÁöµéÀ» Á¶ÇÕÇÏ¿© ¸ðÀÚÀÌÅ©·Î ³ªÅ¸³»´Â ¹æ¹ýÀÌ´Ù. ÀϹÝÀûÀ¸·Î Æ÷Åä ¸ðÀÚÀÌÅ© ¹æ¹ýÀº ±ÕÀÏÇÑ »ç°¢Çü ¸ð¾çÀÇ Å¸ÀÏÀ» ÀÌ¿ëÇÑ´Ù. ±×·¸±â ¶§¹®¿¡ À̹ÌÁö Ư¼º¿¡ µû¸¥ ¸ðÀÚÀÌÅ© Ç¥Çö ¹æ¹ý¿¡ Á¦ÇÑÀÌ ÀÖ´Ù. º» ³í¹®¿¡¼­´Â ´Ù¾çÇÑ Å©±âÀÇ Å¸ÀÏÀ» »ý¼ºÇϱâ À§ÇØ »çÁøÆ®¸®(Quad-tree) ±¸Á¶¸¦ ÀÌ¿ëÇÑ Æ÷Åä ¸ðÀÚÀÌÅ© ¹æ¹ýÀ» Á¦¾ÈÇÑ´Ù. ¸ÕÀú ±×·¡ÇÈ Çϵå¿þ¾îÀÇ ¹Ó¸Ê(mipmap)À» ÀÌ¿ëÇØ ÀÔ·Â À̹ÌÁöÀÇ ·¹º§º° »öºÐ»êÀ» ±¸ÇÑ´Ù. ºÐ»êÀÇ Å©±â¿¡ µû¶ó ÀÔ·Â À̹ÌÁö´Â »çÁøÆ®¸® ±¸Á¶¸¦ °¡Áö´Â ´Ù¾çÇÑ Å©±âÀÇ Å¸ÀÏ·Î ³ª´¶´Ù. °¢°¢ÀÇ Å¸ÀÏÀº Èĺ¸ À̹ÌÁöµé Áß °¡Àå À¯»çÇÑ À̹ÌÁö ã¾Æ ´ëüÇÑ´Ù. °á°úÀûÀ¸·Î ¿ì¸®°¡ Á¦¾ÈÇÏ´Â ¹æ¹ýÀº ÀÔ·Â À̹ÌÁöÀÇ »ö¿¡ µû¶ó ´Ù¾çÇÑ Å©±âÀÇ Å¸ÀÏ·Î ³ª´¸À¸·Î½á ¶Ç ´Ù¸¥ ¸ðÀÚÀÌÅ© È¿°ú¸¦ Á¦°øÇÑ´Ù. ¶ÇÇÑ ¸ðµç °úÁ¤Àº ±×·¡ÇÈ Çϵå¿þ¾î¸¦ ÅëÇØ °è»êµÊÀ¸·Î ºü¸¥ ¼öÇà¼Óµµ¸¦ °®´Â´Ù.

[±¹³»³í¹®]

Syncoms ±×·ì °è¿­»çÀÎ Print Express´Â ÄÚ´Ú ³Ø½ºÇÁ·¹½º Æ÷Åä 3900À» È°¿ëÇØ PrinterPix¿¡ ¼º°øÀûÀ¸·Î °³ÀθÂÃãÈ­µÈ »çÁø ¼±¹° Á¦Ç°°ú »çÁøÀ» °øÀ¯ÇÏ´Â ºñÁî´Ï½º¸¦ ½ÃÀÛÇß´Ù. PrinterPix´Â ¿µ±¹ ¶óÀ̽½¸³ ³²ºÎ 5°³ Áö¿ªÀ» ±â¹ÝÀ¸·Î ÇÏ°í ÀÖ´Â Syncoms ±×·ìÀÇ »õ·Î¿î °è¿­»ç·Î »çÁø°ú ¼ÒºñÀç ½ÃÀå¿¡ ÁýÁßÇÏ°í ÀÖ´Ù.

[±¹³» ÇÐÀ§³í¹®]

À¥ÀÇ µîÀå°ú µ¥ÀÌÅͺ£À̽º ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀº Á¤º¸½Ã½ºÅÛ¿¡ Á¤º¸ÀÇ °øÀ¯¿Í ºÐ»êÀ̶ó´Â »õ·Î¿î ¸íÁ¦¸¦ ´øÁ®ÁÖ¾ú´Ù. ÀÌ¿¡ ´Ù¾çÇÑ ÇüÅÂÀÇ ÀÚ·áµéÀÌ µðÁöÅÐ ¶óÀ̺귯¸®¶ó´Â À̸§À¸·Î ÀúÀåµÇ°í °øÀ¯µÇ¾î Áö°í ÀÖ´Ù. ±×·¯³ª ÀÚ·áÀÇ ÇüÅ°¡ »óÀÌÇÑ Æ÷Åä ¶óÀ̺귯¸®ÀÇ ±¸ÃàÀº ¹ÌºñÇÏ´Ù. º» ¿¬±¸¿¡¼­´Â ¸ÕÀú ±âÁ¸ÀÇ µðÁöÅÐ ¶óÀ̺귯¸® ½Ã½ºÅÛµéÀ» »ìÆ캸°í Æ÷Åä ¶óÀ̺귯¸® ½Ã½ºÅÛ °³¹ß¿¡ ¹Ý¿µµÇ¾î¾ß ÇÒ ±âº»ÀûÀΠƯ¼ºµé¿¡ ´ëÇÏ¿© ³íÀÇÇÏ¿´´Ù. ´ÙÀ½À¸·Î º» ¿¬±¸¿¡¼­´Â À¥ Æ÷Åä ¶óÀ̺귯¸® ½Ã½ºÅÛÀ» °³¹ßÇÏ°íÀÚ ÇÒ ¶§ °í·ÁÇØ¾ß ÇÒ µ¥ÀÌÅͺ£À̽ºÀÇ ¼³°è¿Í À¥ ¼­ºñ½º ÀÎÅÍÆäÀ̽ºÀÇ °³¹ß¿¡ ´ëÇÏ¿© ³íÀÇÇÑ´Ù. º¹ÀâÇÏ°í ´Ù¾çÇÑ Á¤º¸µéÀ» È¿À²ÀûÀ¸·Î Á¶Á÷È­ÇÏ´Â À¥ Æ÷Åä ¶óÀ̺귯¸® ½Ã½ºÅÛÀ» ±¸ÃàÇϱâ À§ÇÑ ¼±Çà°úÁ¤À¸·Î¼­ »ç¿ëÀÚµéÀÇ ¿ä±¸»çÇ× ºÐ¼®¿¡¼­ºÎÅÍ ±¸Çö¿¡ À̸£±â±îÁöÀÇ °³³äÀû ¸ðµ¨µéÀ» ¸¸µé¾î º¸¾Ò´Ù. ÀÌ·¯ÇÑ °úÁ¤À» ¼³¸íÇϱâ À§ÇÏ¿© 'Photo&.com' À̶ó´Â À¥ »çÀÌÆ® ±¸ÃàÀ» ¿¹·Î µé¾î ¸ðµ¨¸µÀ» ÇÏ°í, MicrosoftÞäÀÇ Windows 2000 Server¿Í IIS 5.0±â¹ÝÀ¸·Î MS-SQL 2000°ú ASP¸¦ ÀÌ¿ëÇÏ¿© À¥ Æ÷Åä ¶óÀ̺귯¸® ½Ã½ºÅÛÀ» °³¹ßÇÏ¿´´Ù. ÀÌ ¿¬±¸¿¡¼­ Á¦°øÇÑ Æ÷Åä ¶óÀ̺귯¸®¸¦ À§ÇÑ °³³äÀû ¸ðµ¨°ú µ¥ÀÌÅͺ£À̽ºÀÇ ¼³°è, ±×¸®°í À¥ ¼­ºñ½º ÀÎÅÍÆäÀ̽ºÀÇ °³¹ßÀº À¥ ±â¹ÝÀÇ Æ÷Åä ¶óÀ̺귯¸® ½Ã½ºÅÛÀ» °³¹ßÇÏ°íÀÚ ÇÏ´Â À̵鿡°Ô ÁÁÀº ÂüÁ¶¸ðµ¨·Î °øÇåÇÒ ¼ö ÀÖÀ» °ÍÀÌ´Ù.

[±¹³»³í¹®]

[±¹³»³í¹®]

[±¹³»³í¹®]

[±¹³»³í¹®]

[±¹³»³í¹®]

[±¹³»³í¹®]

[±¹³»³í¹®]

/ 101

Filters

º¸±âÇü½Ä

Á¤·Ä¼ø¼­

Æ÷¸Ë

¸®½ºÆ® ¼ö